Humacyte, Inc. (HUMA) Misses Q3 EPS by 2c

Humacyte, Inc. (NASDAQ: HUMA) reported Q3 EPS of ($0.25), $0.02 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $30 thousand versus the consensus estimate of $236.02 thousand.

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• Snail, Inc. (SNAL) Reports Q3 Loss of $0.36
• Mount Logan Capital Inc. (MLCI) Reports Q2 Loss of $0.37